Showing results (11-20 of 126) with videos related to
Sort By:
Pageof 13
International Immunology|August 19, 2007
Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infectionSandhya Vasan, Michael A Poles, Amir Horowitz, et al.Vaccine|November 9, 2011
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in miceGerasimos J Zaharatos, Jian Yu, Craig Pace, et al.Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvantXiangming Li, Masakazu Fujio, Masakazu Imamura, et al.Clinical and Vaccine Immunology : CVI|July 28, 2012
A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteersJakub Kopycinski, Hannah Cheeseman, Ambreen Ashraf, et al.Transgender Health|August 2, 2023
Unique HIV Risk Factors and Prevention Needs for Transgender Women and Cisgender Men Who Have Sex with Men in Bangkok, ThailandNicole Dear, Leilani Francisco, Punnee Pitisutthithum, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 12, 2021
Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIVCamilla Muccini, Trevor A Crowell, Suteeraporn Pinyakorn, et al.Journal of Immunology Research|July 21, 2025
Poxvirus Vectors Activate Human NK and MAIT Cells in a Type I Interferon, IL-18, and Monocyte-Dependent MannerKombo F N'guessan, Zhanna Shubin, Kawthar Machmach, et al.Vaccine|November 25, 2010
Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporationKaren E Dolter, Claire F Evans, Barry Ellefsen, et al.Journal of Virology|November 27, 2004
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10Saurabh Mehandru, Terri Wrin, Justin Galovich, et al.Plos One|January 26, 2013
Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic reviewMarnie L Elizaga, Sandhya Vasan, Mary A Marovich, et al.Pageof 13